1 / 44

A Case of Cauliflower Ears

A Case of Cauliflower Ears. Hilary Rowe, BScPharm VIHA Pharmacy Resident 2009-10 Pain Clinic Rotation. Outline. Objectives Background Patient Case Clinical Question Review of Evidence Recommendation Monitoring. Objectives.

bart
Download Presentation

A Case of Cauliflower Ears

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A Case of Cauliflower Ears Hilary Rowe, BScPharm VIHA Pharmacy Resident 2009-10 Pain Clinic Rotation

  2. Outline • Objectives • Background • Patient Case • Clinical Question • Review of Evidence • Recommendation • Monitoring

  3. Objectives • Describe 1 way inflammation destroys cartilage in relapsing polychondritis (RP) • Name 3 risk factors for addiction in a pain patient • Be familiar with the evidence of disease modifying agents in RP

  4. Relapsing Polychondritis • Destruction of cartilage and replacement with fibrous tissue • Autoantibodies to type II, IX, XI collagen causes inflammatory infiltration • Produce Th1 cytokines (TNF-α) by T-cell clones reactive to Type II collagen • Lysosomal enzyme release eventually results in destruction of the cartilage

  5. Diagnostic Criteria Presence of 3 or more: • Recurrent chondritis both auricles • Non-erosive inflammatory polyarthritis • Nasal chondritis • Ocular inflammation • Respiratory tract chondritis • Cochlear &/or vestibular dysfunction

  6. Symptoms

  7. Treatment ? Methotrexate, Colchicine, Dapsone, Hydroxychloroquine Treat inflammation-Prednisone Treat pain-NSAIDS Diagnosis

  8. Mrs. MJ • ID: 40 yo female, ht 155cm, wt 62kg • CC: Acute decline in functioning with widespread pain and stiffness in joints • HPI Nov 2009:Current RP flare of longest duration; walking this summer and now in motorized wheel chair since September • RP diagnosed Aug 2009, polyarthritis since 2005

  9. Mrs. MJ • PMHx:Transposition of ureters 1983- Recurrent UTI’s (prior to surgery 8-9/year, after surgery 1-2/year) • Allergies: Lactose (hives & difficulty breathing)

  10. Mrs. MJ • Social & Family Hx: • Lives with husband & two teenagers • Prior to attack was running an event planning business • Both parents were alcoholics • Discharge Plan from Pain Clinic: • Improve pain control & function

  11. Medical Problem List Active: • Prolonged flare of RP • Pain • Constipation Chronic: • Depression • Osteopenia • RP • Graves disease • Pain

  12. Review of Systems

  13. Score is 5: • 3 points family history • 1 point age • 1 point depression • Other factors: • Drug seeking • Altering routes • Running out early • Rx forgery • Stealing • ↑ dose with no change in disease state

  14. Review of Systems

  15. Review of Systems

  16. Review of Systems

  17. Review of Systems

  18. Review of Systems

  19. Pain History Paroxysmal attacks: • Left side more affected then right • Described: red-hot poker stabbing and digging into her • 20/10 causing her to sob, occurs with flares • What makes it better-? more medication • What makes it worse- Nothing

  20. Pain History Baseline aches: • Widespread: Nose, chest, sternum, jaw, elbows, back, shoulders, wrists, hands, hips, ankles • Described: ache • What makes it better-baths, medication • What makes it worse- > 300-400 steps per a day

  21. DRPs • MJ has a prolonged polychondritis flare and is experiencing additional pain not controlled by her current therapies • MJ is experiencing constipation secondary to narcotics and immobility and could benefit from a regular bowel routine

  22. DRPs • MJ has a prolonged flare of polychondritis and could potentially benefit from re-evaluation of her disease modifying agents

  23. Question • Are there any disease-modifying therapies that might be helpful for Mrs. MJ’s prolonged flare of relapsing polychondritis, taking into consideration the medications she has already tried?

  24. Therapeutic Options • No change in therapy • Infliximab • Rituximab • Azathioprine • Cyclophosphamide

  25. Clinical Question

  26. Search Strategy • PubMed, Embase, Google • Search terms: • Relapsing polychondritis • Disease modifying agents • Autoimmune diseases • Found • 3 case reports, 1 retrospective review

  27. Leroux et al. Arthritis & Rheumatism 2009

  28. Leroux et al. Arthritis & Rheumatism 2009

  29. Leroux et al. Arthritis & Rheumatism 2009 • Results: • 2 partial remissions • 4 stable • 3 worsened • 2 added new immunosuppressants • 2 increased steroid dose • 6 benefitted- at 12 months 2 remained stable & 4 were worse

  30. Leroux et al. Arthritis & Rheumatism 2009

  31. Marie et al. Rheumatology 2009

  32. Buonuomo et al. Rheumatol Int 2009

  33. Richez et al. Rheumatol Int 2009

  34. Goals of Therapy Patients Goals • Improve pain control • Increase mobility and ADL • Return to work Team Goals • Improve pain control • Increase mobility and ADL • Slow progression of disease • Decrease morbidity & mortality • Minimize adverse drug events

  35. Recommendation • No definitive evidence to support suggesting a disease-modifying agent • Risks and benefits of infliximab should be discussed with patient • Patient should make an informed decision to start therapy

  36. Recommendation • Improve pain control • Discontinue Codeine Contin • Start Morphine 30mg long acting q 12h • Start Morphine IR 5mg prn for breakthrough pain

  37. Recommendation • Codeine Contin ineffective pain 20/10, poor sleep, dose above ceiling effect of 400mg/day • Morphine is effective for breakthrough pain • Morphine less potential for abuse then hydromorphone and oxycodone • SR formulation less potential for abuse

  38. Monitoring

  39. Monitoring

  40. Follow Up- Feb 2010 • Patient switched from Codeine Contin to Morphine (↓ IR 2 daily to 2-3 nights/wk) • Currently ↓ prednisone dose • Patient wanted to trial dapsone & colchicine 1st (DMARD was not started) • Patient now considering DMARD option • Constipation improving

  41. Questions?

  42. References • Kahan M, Srivastava A, Wilson L et al. Misuse of and dependence on opioids: study of chronic pain patients. Canadian Family Physician 2006;52:1081-87. • Marie I, Lahaxe L, Josse S, Levesque H. Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement. Rheumatology 2009 Oct;48(10):1328-33. • Leroux G, Costedoat-Chalumeau N, Brihaye B, et al. Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients. Arthritis Rheumatology 2009 May 15;61(5):577-82. • Buonuomo PS, Bracaglia C, Campana A, et al. Relapsing polychondritis: new therapeutic strategies with biological agents. Rheumatology International. 2009 Aug 15. [Epub ahead of print]. • RichezC, Dumoulin X, Schaeverbeke T. Successful treatment of relapsing polychondritis with infliximab. Clinical and Experimental Rheumatology 2004;22:629-31. • PorroGB, Lazzaroni M, Imbesi V et al. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study. Digestive and Liver Disease 2000 April; 32(3): 201-208.

More Related